Metabolic gene polymorphisms and p53 mutations in healthy centenarians and younger controls

References

• BIRGANDER, R., SJALANDER, A., RANNUG, A., ALEXANDRIE, A. K 0., INGELMAN STJNDBERG, M., SEIDEGARD, J., TORNIING, G., BECKMAN, G. and BECKMAN, L 1995, p53 polymorphisms and haplotypes in lung cancer. Carcinogenesis, 16, 2233–2236.
   Google Scholar
• BIRO, E., KALINA, I., SALAGOVIC, J., HABALOVA, V, HRIVAK, M. and VALANSKY, L 2000, p53 single nucleotide polymorphisms and bladder cancer. Neoplasma, 47, 303–306.
   Google Scholar
• BIROS, E., KALINA, I., KOHUT, A., STUBNA, J. and SALAGOVIC, J. 2001, Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer. Lung Cancer, 31, 157–162.
   PubMedGoogle Scholar
• BONAFE, M., OLIVIERI, F., MARIV, D., BAGGIO, G., MATTACE, R, SANSONI, P., DE BENEDICTIS, G., DE LUCA, M., BERTOLINI, S., BARBI, C., MoN-ri, D. and FRANCESCHI, C. 1999, p53 variants predisposing to cancer are present in healthy centenarians. American Journal of Human Genetics, 64, 292–295.
   Google Scholar
• D'ERRico, A., MALATS, N., VINEIS, P. and BOFNETTA, P. 1999, Review of studies of selected metabolic polymorphisms and cancer. IARC Scientific Publications, 148, 323–393.
   Google Scholar
• FRANCESCHI, C., MOT-FA, L., VALENSIN, S., RAPISARDA, R., FRANZONE, A., BERARDEII-I, M., MOTTA, M., BONAFE, M., FERRUCCI, L., DEIANA, L., PES, G., CARRU, C., DESOLE, S., BARBI, C., GEMELII, C., LESCAI, F., OLIVIERI, F., MARCHEGIANI, F., CARDELII, M., CAVAII-ONE, L., GTJERESI, P., COSSARIZZA, A., TROIANO, L., Pim, G., SANSONI, P., PASSERI, G., LISA, R., SPAZZAFUMOO, L., AMADIO, L., GIUNTA, S., STECCONI, R., MORRESI, R., VITICCHI, C., MATTACE, R., DE BENEDICTIS, G., BAGGIO, G. and THE ITALIAN MULTICENTER STTJDY ON CENTENARIANS (IMUSE). 2000, Do men and women follow different trajectories to reach longevity? Aging (Milano), 2, 77–84.
   Google Scholar
• GARTE, S., GANGULY, S. and TATOU, E. 2003, Effect of genotype on steady-state CYP1A1 gene expression in human peripheral lymphocytes. Biochemical Pharmacology, 65, 441–445.
   PubMedGoogle Scholar
• GARTE, S., GASPARI, L., ALExANDRIE, A. K., AMBROSONE, C., AUTRUP, H., AUTRUP, J. L., BARANOVA, H., BATHUM, L., BENHAMOU, S., BOFFETTA, P., BOUCHARDY, C., BRESKVAR, K., BROCKMOL-LER, J., CASCORBI, I., CLAPPER, M. L., Cou-rELLE, C., DALY, A., DELuOmo, M., DOI-ZAN, V3 DRESLER, C. M., FRYER, A., HAUGEN, A., HEIN, D. VV., HILDESHEIM, A., HIRVONEN, A., HSIEH, L. L., INGELMAN-SUNDBERG, M., KALINA, I., KANG, D., KIHARA, M., KIYOHARA, C., KREMERS, P., LAZARUS, P., LE MARCHAND, L., LECHNER, M. C., VAN LIESHOUT, E. M., LONDON, S., MANNI, J. J., MAUGARD, C. M., MORITA, S., NAZAR-STEWART, V, NODA, K., ODA, Y., PARL, F. F., PASTORELII, R., PERSSON, I., PETERS, W. H., RANNUG, A., REBBECK, T., RISCH, A., ROELANDT, L., ROMKES, M., RYBERG, D., SALAGOVIC, J., SCHOKET, B., SEIDEGARD, J., SHIELDS, P. G., Sim, E., SINNET, D., STRANGE, R. C., STTJCKER, I., STJGIMTJRA, H., TO-FIGTJERAS, J., VINEIS, P., Yu, M. C. and TATOU, E. 2001, Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiology, Biomarkers and Prevention, 10, 1239–1248.
   Google Scholar
• HOUSTEIN, M., SLDRANSKY, D., VOGELSTEIN, B. and HARRIS, C. C. 1991, p53 mutations in human cancers. Science, 253, 49–53.
   PubMedGoogle Scholar
• JOHNSON, T. E. 1997, Genetic influences on aging. Experimental Gerontology, 32, 11–22.
   PubMedGoogle Scholar
• KINZLER, K W. and VOGELSTEIN, B. 1997, Cancer-susceptibility genes. Gatekeepers and caretakers. Nature, 386, 761–763.
   PubMed Web of Science ®Google Scholar
• LAW, J. C., STRONG, L. C., CHLDAMBARAM, A. and FERRELL, R. E. 1991, Germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Research, 51, 6385–6387.
   PubMedGoogle Scholar
• LAZAR, V, HAZARD, F., BERTIN, F., JANIN, N., BELLET, D. and BRESSAC, B. 1993, Simple sequence repeat polymorphism within the p53 gene. Oncogene, 8, 1703–1705.
   PubMed Web of Science ®Google Scholar
• LEROI, A. M., KOUFOPANOU, V. and BURT, A. 2003, Cancer selection. Nature Reviews, Cancer, 3, 226–231.
   PubMed Web of Science ®Google Scholar
• LIU, G., MILLER, D. P., ZHOU, W, THURSTON, S. W., FAN, R, XU, L. L, LYNCH, T. J., WAIN, J. C., SU, L. and CHRISTIANI, D. 2001, Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Research, 61, 8718–8722.
   PubMed Web of Science ®Google Scholar
• MCDANIEL, T., CARBONE, D., TAKAHASHI, T., CHUMAKOV, P., CHANG, E. H., PIROLLO, K F., YIN, J., HUANG, Y. and MELTZER, S. J. 1991, The Msp 1 polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products. Nucleic Acids Research, 19, 4796.
   PubMed Web of Science ®Google Scholar
• MILLER, D. P., Liu, G., DE VIVO, I., LYNCH, T. J., WAIN, J. C., Su, L and CmusTIANI, D. 2002, Combinations of the variant genotypes of GSTPI, GSTMI, and p53 are associated with an increased lung cancer risk. Cancer Research, 62, 2819–2823.
   Google Scholar
• ROFF, D. A. and BENTZEN, P. 1989, The statistical analysis of mitochondrial DNA polymorphisms: chi square and the problem of small samples. Molecular Biology and Evolution, 6, 539-545. SJÄLANDER, A., BIRGANDER, R., KivELA, A. and BECKMAN, G. 1995, p53 polymorphisms and haplotypes in different ethnic groups. Human Heredity, 45, 144–149.
   Google Scholar
• SJALANDER, A., BIRGANDER, R., HALUMANS, G., CAJANDER, S., LENNER, P., ATHLIN, L., BECKMAN, G. and BECKMAN, L. 1996, p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis, 17, 1313–1316.
   PubMed Web of Science ®Google Scholar
• SJALANDER, A., BIRGANDER, R., KIVELA�, A. and BECKMAN, G. 1995, p53 polymorphisms and haplotypes in different ethnic groups. Human Heredity, 45, 144–149.
   Google Scholar
• TAIOLI, E., TRACHMAN, J., CHEN, X., TONIOLO, P. and GARTE, S. J. 1995, A CYPIAI restriction fragment length polymorphism is associated with breast cancer in African—American women. Cancer Research, 55, 3757–3758.
   PubMed Web of Science ®Google Scholar
• TAIOLI, E., MARI, D., FRANCESCHI, C., BONAFE, M., MoNrri, D., BERTOLINI, S., MARINELLI, D. and GARTE, S. 2001, Polymorphisms of drug-metabolizing enzymes in healthy nonagenarians and centenarians: difference at GSTTI locus. Biochemical and Biophysical Research Communications, 280, 1389–1392.
   PubMed Web of Science ®Google Scholar
• THOMAS, M., KALITA, A., LABRECQUE, S., Pim, D., BANKS, L. and MATLASHEWSKI, G. 1999, Two polymorphic variants of wild-type p53 differ biochemically and biologically. Molecular and Cellular Biology, 19, 1092–1100.
   PubMed Web of Science ®Google Scholar
• VINEIS, P., VEGLIA, F., BENHAMOU, S., BTJTKIEWICZ, D., CASCORBI, I., CLAPPER, M. L., DOLZAN, V., HAUGEN, A., HIRVONEN, A., INGELMAN-SUNDBERG, M., KIHARA, M., KIYOHARA, C., KREMERS, P., LE MARCHAND, L., OHSHIMA, S., PASTORELLI, R, RANNUG, A., ROMKES, M., SCHOKET, B., SHIELDS, P., STRANGE, R. C., STTJCKER, I., STJGIMTJRA, H., GARTE, S., GASPARI, L. and TATOU, E. 2003, CYPIAI T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. International Journal of Cancer, 104, 650–657.
   Google Scholar
• WANG-GOHRKE, S., WEIKEL, W., RISCH, H., VESPRINI, D., ABRAHAMSON, J., LERMAN, C., GODWIN, A., MOSLEHI, R., OLIPADE, 0., BRUNET, J. S., STICKELER, E., KREIENBERG, R, WEBER, B., NAROD, S. A. and RUNNEBAUM, I. B 1999, Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. British Journal of Cancer, 81, 179–183.
   Google Scholar
• WANG-GOHRKE, S., BECHER, H., KREIENBERG, R., RTJNNEBATJM, I. B. and CHANG-CLOTJDE, J. 2002, Intron 3 16 bp duplication polymorphism of p53 is associated with an increase risk for breast cancer by the age of 50 years. Pharmacogenetics, 12, 269–272.
   Google Scholar
• WANT, M. A., ZUU, Q., ELIVIAMPY, M., VENKATACHALAM, S. and WANT, A. A. 2000, Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells. Cancer Research, 60, 2273–2280.
   PubMedGoogle Scholar